Company News
Company News

2026-09-03
BojiMed and Huawei Sign Cooperation Agreement to Jointly Build a New AI+CRO Intelligent R&D Paradigm

2026-08-05
Boji's Expert Stewardship | Astem-101 Stem Cell Therapy Investigator Seminar Concludes with Resounding Success

2026-08-04
Omalizumab for Injection (Shuyang Shule®) Approved for Market Launch! BojiMed Supports Its Phase III Clinical Research

2026-08-03
BojiMed Signs Phase I–II Clinical Project Agreement with Beijing Shunxin Xiangyu for Active Inflammatory Bowel Disease, Opening a New Chapter of In-Depth Collaboration

2026-06-29
BojiMed Named Among China's Top 10 Pharmaceutical CRO Enterprises for 2026 (Ranked 8th)

2026-06-04
BojiMed Contributes to World's First Transcriptome-Based Standard for Medicinal Resource Discovery

2026-06-03
Delegation from Sweden’s Uppsala Monitoring Centre Visits Boji Medical Beijing for In-Depth Discussions

2026-06-01
Boji Medical Wins CGCS Rising Star Award for Best CRO Partner in CGT Sector

2026-05-28
Boji Medical Provides Full-Program Support as Arnovie101 Shows Positive Early Clinical Signals with Favorable Efficacy and Safety Profile

2026-05-21